Neurocrine Bioscience buy Wedbush
Start price
31.07.25
/
50%
€115.25
Target price
31.07.26
€123.35
Performance (%)
12.93%
Price
12.12.25
€130.15
Summary
This prediction is currently active. The BUY prediction by Wedbush currently has a performance of 12.93%. This prediction currently runs until 31.07.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Wedbush for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Wedbush from $137.00 to $141.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wedbush for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
-
06.05.26
06.05.26
22.90%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.50
07.02.25
07.02.25
€142.21
07.02.26
07.02.26
11.72%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.25
16.12.24
16.12.24
€140.81
16.12.25
16.12.25
5.60%
12.12.25
12.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.80
29.05.24
29.05.24
€140.10
29.05.25
29.05.25
-10.86%
30.05.25
30.05.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€127.63
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24